1 min read
The Medicare NGS NCD grants national coverage for somatic testing in patients with advanced cancer if the test has FDA-approval or -clearance as a companion diagnostic, and has a FDA-approved or -cleared indication for use in that patient’s cancer....
Read More
[dpvfw_pdf_viewer_embed pdfviewer=”2796″ zoom_pdf=”page-fit” _builder_version=”4.18.0″ _module_preset=”default” hover_enabled=”0″...
3 min read
Background A leading global medical device manufacturer faced a pricing strategy challenge and partnered with Veranex (formerly Boston Healthcare...
5 min read
Part 1: Providers and Regulators Getting information on the nuclear medicine market landscape, regulations, and market access environment in China...
